Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for NDA 050566

Expand all

ANCEF IN DEXTROSE 5% IN PLASTIC CONTAINER (CEFAZOLIN SODIUM)
EQ 10MG BASE/ML
Marketing Status: Discontinued

Active Ingredient: CEFAZOLIN SODIUM
Proprietary Name: ANCEF IN DEXTROSE 5% IN PLASTIC CONTAINER
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: EQ 10MG BASE/ML
Reference Listed Drug: Yes
Reference Standard: No
TE Code: 
Application Number: N050566
Product Number: 003
Approval Date: Jun 8, 1983
Applicant Holder Full Name: BAXTER HEALTHCARE CORP
Marketing Status:  Discontinued
Patent and Exclusivity Information

ANCEF IN DEXTROSE 5% IN PLASTIC CONTAINER (CEFAZOLIN SODIUM)
EQ 20MG BASE/ML
Marketing Status: Discontinued

Active Ingredient: CEFAZOLIN SODIUM
Proprietary Name: ANCEF IN DEXTROSE 5% IN PLASTIC CONTAINER
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: EQ 20MG BASE/ML
Reference Listed Drug: Yes
Reference Standard: No
TE Code: 
Application Number: N050566
Product Number: 004
Approval Date: Jun 8, 1983
Applicant Holder Full Name: BAXTER HEALTHCARE CORP
Marketing Status:  Discontinued
Patent and Exclusivity Information

ANCEF IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER (CEFAZOLIN SODIUM)
EQ 10MG BASE/ML
Marketing Status: Discontinued

Active Ingredient: CEFAZOLIN SODIUM
Proprietary Name: ANCEF IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: EQ 10MG BASE/ML
Reference Listed Drug: Yes
Reference Standard: No
TE Code: 
Application Number: N050566
Product Number: 001
Approval Date: Jun 8, 1983
Applicant Holder Full Name: BAXTER HEALTHCARE CORP
Marketing Status:  Discontinued
Patent and Exclusivity Information

ANCEF IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER (CEFAZOLIN SODIUM)
EQ 20MG BASE/ML
Marketing Status: Discontinued

Active Ingredient: CEFAZOLIN SODIUM
Proprietary Name: ANCEF IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: EQ 20MG BASE/ML
Reference Listed Drug: Yes
Reference Standard: No
TE Code: 
Application Number: N050566
Product Number: 002
Approval Date: Jun 8, 1983
Applicant Holder Full Name: BAXTER HEALTHCARE CORP
Marketing Status:  Discontinued
Patent and Exclusivity Information